Abstract:Objective: To investigate the feasibility and value of interphase fluorescence in situ hybridization (FISH) in the pathological diagnosis, differential diagnosis and therapeutic assessment of B-cell lymphomas. Methods: The cohort included 604 cases of B-cell lymphoma which were collected at West China Hospital from May 2010 to December 2016.And all were subjected to interphase FISH using 11 break apart or fusion probes (MYC, bcl-2, bcl-6, IRF4, MYC/IgH, bcl-2/IgH, CCND1/IgH, IgH, API2/MALT1, p53/ATM, and D13S319/CEP12). Results: The median age of the 604 B-cell lymphoma patients was 47.7 (aged 2-90) years including 372 men and 232 women. All the cases was divided into 463 large B cell lymphomas(LBL) and 141 small B cell lymphomas, and the total interphase FISH positive rate was 59.8% (361/604). Among the 463 LBL, 12.5% (58/463), 9.5% (44/463) and 2.2% (10/463) of cases showed MYC, bcl-6 and bcl-2 gene rearrangements respectively; and 363 diffuse large B cell lymphoma (DLBCLs) were reclassified as germinal center B-cell (GCB) subtype (38.6%, 140/363) and non-GCB subtype (61.4%, 223/363) by Hans algorithm. The rearrangement rates in GCB and non-GCB DLBCL were 45.7%(64/140)and 21.5%(48/223; P=0.001), respectively. Compared to the non-GCB DLBCL, GCB DLBCL showed higher MYC and bcl-2 gene rearrangements (P=0.001). Eleven (2.4%, 11/463) cases had MYC and bcl-6 or bcl-2 gene rearrangement (double-hit lymphoma); one (0.2%, 1/463) case had MYC, bcl-6 and bcl-2 gene rearrangements (triple-hit lymphoma); two (0.4%, 2/463) cases had bcl-2 and bcl-6 gene rearrangements. MYC translocation and MYC/IgH fusion were detected in 94.2%(81/86) and 83.7%(72/86) cases of Burkitt lymphomas. IRF4 rearrangement was detected in two cases of IRF4+ LBCL. Genetic abnormalities were detected in 9/19, 100%(29/29), 30.8%(12/39) and 68.5%(37/54) cases of follicular lymphoma, mantle cell lymphoma, MALT lymphoma and chronic lymphocytic leukemia, respectively. Conclusions: Interphase FISH can rapidly and accurately detect the genetic changes in B-cell lymphomas. Different genetic changes are specifically valuable to the diagnosis, differential diagnosis, prognosis evaluation and treatment guidance of various B-cell lymphomas.

Fluorescence In-Situ Hybridization As a Diagnostic Tool for Cutaneous Melanoma

Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus

Progress in the application of FISH for the molecular characterization of lymphomas

Fluorescence in Situ Hybridisation As an Ancillary Tool in the Diagnosis of Acral Melanoma: a Review of 44 Cases

Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions

Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma

Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma

[Fluorescence in Situ Hybridization Identifies Complex Chromosomal Aberrations in Multiple Myeloma].

Molecular skin fluorescence imaging: A tool for evaluating early melanoma development

Detection of Chromosomal Aberration in Paraffin-Embedded Synovial Sarcoma Tissues by Fluorescence In-Situ Hybridization

Fluorescence in Situ Hybridization in Surgical Pathology: Principles and Applications

Fluorescence in Situ Hybridization Analysis of Chromosome Aberrations in 60 Chinese Patients with Multiple Myeloma

Clinical Application of Multicolor Fluorescence in Situ Hybridization on Early Diagnosis of Lung Cancer

[Diagnostic and Therapeutic Values of Interphase Fluorescence in Situ Hybridization in B-cell Lymphomas: a Clinicopathologic Analysis of 604 Cases].

Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing

Towards label‐free non‐invasive autofluorescence multispectral imaging for melanoma diagnosis

Application of Multicolor Fluorescence in Situ Hybridization to Early Diagnosis of Esophageal Squamous Cell Carcinoma

Clinicopathological, Immunohistochemical and Fluorescence In‐situ Hybridisation Features of Early Subungual Melanoma: an Analysis of 65 Cases

Molecular diagnosis in early mycosis fungoides using T-cell receptor gene rearrangement by laser capture microdissection and genescan

[Fluorescence in Situ Hybridization Combined with Cytomorphology for the Detection of Lung Cancer in Bronchial Brushing Specimens].

Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma